Early Cancer Detection: The Role of Tumour Marker Blood Tests in Dubai
Effective treatment requires early discovery, particularly in cases of cancer, which is the world's leading cause of death. It is the third most common cause of death in the United Arab Emirates. Nonetheless, when detected in their early stages, the majority of cancer types may be successfully treated. By detecting different malignancies early on, cancer marker screening in Dubai helps save and extend lives.
Understanding the Basics: What is Cancer Screening?
Cancer screening is simply a series of procedures intended to identify potentially cancerous cells or other early indicators of the disease even before symptoms appear. The likelihood of a favourable outcome from cancer therapy is greatly increased with early identification.
It is an essential part of preventative healthcare since it may sometimes even stop cancer from starting or spreading.
Common Cancers Screened in Dubai
Early cancer identification is vital, and screening is a key component. Cervical, breast, colon, prostate, and lung cancers are among the most often tested forms.
The highest chances of a favourable outcome from therapy are provided by early cancer detection. For this reason, regardless of risk factors, routine cancer screenings, including blood testing for tumour markers, are strongly advised for everyone.
The Importance of Recognising Early Symptoms
When cancer starts to grow, it can put pressure on blood vessels, nerves, and organs in the surrounding area. It can cause many symptoms, such as changes in weight that don't make sense, lumps, weariness, eating problems, discomfort, coughing, skin changes, abnormal bleeding, headaches, and more. It is critical to pay attention to your body and any unexpected changes since recognising these symptoms might be the first step towards obtaining an early diagnosis.
Different Types of Tumour Marker Tests in Dubai
Tumour marker blood tests in Dubai provide crucial information about cancer growth rate, treatment options, effectiveness, and potential recurrence. Dubai offers various tests, including tumour marker tests.
CA 125 (cancer antigen 125) test: This test is used to assess the efficacy of treatment for ovarian cancer and to look for cancer recurrence.
CA 27-29 and CA 15-3: These tests evaluate the response to therapy in advanced instances of breast cancer that are monitored.
Prostate-specific antigen, or PSA: It is a blood test that can be used to screen for prostate cancer and aid in diagnosis and treatment monitoring.
Carcinoembryonic antigen, or CEA: It is a test used to measure the efficacy of treatment and monitor for recurrence in patients with colon cancer as well as tumours of the lung, stomach, thyroid, pancreas, breast, and ovary.
AFP (Alpha-fetoprotein): For liver, ovarian, or testicular cancer, this test assists in diagnosis, staging, treatment assessment, and predicting recovery chances.
B2M (Beta 2-microglobulin): Used for multiple myelomas, some lymphomas, and leukaemias to evaluate treatment response and prognosis.
Conclusion
In the realm of healthcare, early cancer detection is a top priority, and Dubai's healthcare system is well-equipped to tackle this challenge. Don't wait; take proactive steps towards your health by undergoing regular screenings, including cancer marker screening in Dubai, to increase your chances of early cancer detection and successful treatment. Your health is your most precious asset, and Dubai's screening facilities are here to help safeguard it.
Comments
Post a Comment